Literature DB >> 28416349

Cytoplasmic body pathology in severe ACTA1-related myopathy in the absence of typical nemaline rods.

Sandra Donkervoort1, Sophelia H S Chan2, Leslie H Hayes3, Nathaniel Bradley1, David Nguyen1, Meganne E Leach4, Payam Mohassel1, Ying Hu1, Mathula Thangarajh5, Diana Bharucha-Goebel4, Amanda Kan6, Ronnie S L Ho6, Christine A Reyes5, Jessica Nance7, Steven A Moore8, A Reghan Foley1, Carsten G Bönnemann9.   

Abstract

Mutations in ACTA1 cause a group of myopathies with expanding clinical and histopathological heterogeneity. We describe three patients with severe ACTA1-related myopathy who have muscle fiber cytoplasmic bodies but no classic nemaline rods. Patient 1 is a five-year-old boy who presented at birth with severe weakness and respiratory failure, requiring mechanical ventilation. Whole exome sequencing identified a heterozygous c.282C>A (p.Asn94Lys) ACTA1 mutation. Patients 2 and 3 were twin boys with hypotonia, severe weakness, and respiratory insufficiency at birth requiring mechanical ventilation. Both died at 6 months of age. The same heterozygous c.282C>A (p.Asn94Lys) ACTA1 mutation was identified by whole exome sequencing. We conclude that clinically severe ACTA1-related myopathy can present with muscle morphological findings suggestive of cytoplasmic body myopathy in the absence of definite nemaline rods. The Asn94Lys mutation in skeletal muscle sarcomeric α-actin may be linked to this histological appearance. These novel ACTA1 cases also illustrate the successful application of whole exome sequencing in directly arriving at a candidate genetic diagnosis in patients with unexpected phenotypic and histologic features for a known neuromuscular gene.
Copyright © 2017. Published by Elsevier B.V.

Entities:  

Keywords:  ACTA1; Congenital myopathies; Cytoplasmic bodies; Skeletal muscle α-actin

Mesh:

Substances:

Year:  2017        PMID: 28416349      PMCID: PMC5918412          DOI: 10.1016/j.nmd.2017.02.012

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  23 in total

1.  Co-existence of nemaline and cytoplasmic bodies in muscle of an infant with nemaline myopathy.

Authors:  Kiyotaka Suwa; Masashi Mizuguchi; Mariko Y Momoi; Minako Nakamura; Kunimasa Arima; Hirofumi Komaki; Ikuya Nonaka
Journal:  Neuropathology       Date:  2002-12       Impact factor: 1.906

2.  Mutations and polymorphisms of the skeletal muscle alpha-actin gene (ACTA1).

Authors:  Nigel G Laing; Danielle E Dye; Carina Wallgren-Pettersson; Gabriele Richard; Nicole Monnier; Suzanne Lillis; Thomas L Winder; Hanns Lochmüller; Claudio Graziano; Stella Mitrani-Rosenbaum; Darren Twomey; John C Sparrow; Alan H Beggs; Kristen J Nowak
Journal:  Hum Mutat       Date:  2009-09       Impact factor: 4.878

3.  The essentiality of histo- and cytochemical studies of skeletal muscle in the investigation of neuromuscular disease. 1962.

Authors:  W K Engel
Journal:  Neurology       Date:  1998-09       Impact factor: 9.910

4.  Mutations in the skeletal muscle alpha-actin gene in patients with actin myopathy and nemaline myopathy.

Authors:  K J Nowak; D Wattanasirichaigoon; H H Goebel; M Wilce; K Pelin; K Donner; R L Jacob; C Hübner; K Oexle; J R Anderson; C M Verity; K N North; S T Iannaccone; C R Müller; P Nürnberg; F Muntoni; C Sewry; I Hughes; R Sutphen; A G Lacson; K J Swoboda; J Vigneron; C Wallgren-Pettersson; A H Beggs; N G Laing
Journal:  Nat Genet       Date:  1999-10       Impact factor: 38.330

5.  Frequency of somatic and germ-line mosaicism in retinoblastoma: implications for genetic counseling.

Authors:  K C Sippel; R E Fraioli; G D Smith; M E Schalkoff; J Sutherland; B L Gallie; T P Dryja
Journal:  Am J Hum Genet       Date:  1998-03       Impact factor: 11.025

6.  Clinical course correlates poorly with muscle pathology in nemaline myopathy.

Authors:  M M Ryan; B Ilkovski; C D Strickland; C Schnell; D Sanoudou; C Midgett; R Houston; D Muirhead; X Dennett; L K Shield; U De Girolami; S T Iannaccone; N G Laing; K N North; A H Beggs
Journal:  Neurology       Date:  2003-02-25       Impact factor: 9.910

7.  Evidence for a dominant-negative effect in ACTA1 nemaline myopathy caused by abnormal folding, aggregation and altered polymerization of mutant actin isoforms.

Authors:  Biljana Ilkovski; Kristen J Nowak; Ana Domazetovska; Adam L Maxwell; Sophie Clement; Kay E Davies; Nigel G Laing; Kathryn N North; Sandra T Cooper
Journal:  Hum Mol Genet       Date:  2004-06-15       Impact factor: 6.150

8.  Histopathologic progression and a novel mutation in a child with nemaline myopathy.

Authors:  Shafeeq Ladha; Stephen Coons; Stanley Johnsen; Nyamkhishig Sambuughin; Ricardo Bien-Wilner; Kumaraswamy Sivakumar
Journal:  J Child Neurol       Date:  2008-05-16       Impact factor: 1.987

9.  Recurrence of perinatal lethal osteogenesis imperfecta in sibships: parsing the risk between parental mosaicism for dominant mutations and autosomal recessive inheritance.

Authors:  Shawna M Pyott; Melanie G Pepin; Ulrike Schwarze; Kathleen Yang; Gretchen Smith; Peter H Byers
Journal:  Genet Med       Date:  2011-02       Impact factor: 8.822

10.  Next-generation sequencing still needs our generation's clinicians.

Authors:  A Reghan Foley; Sandra Donkervoort; Carsten G Bönnemann
Journal:  Neurol Genet       Date:  2015-08-13
View more
  3 in total

1.  Severe ACTA1-related nemaline myopathy: intranuclear rods, cytoplasmic bodies, and enlarged perinuclear space as characteristic pathological features on muscle biopsies.

Authors:  Clémence Labasse; Guy Brochier; Ana-Lia Taratuto; Bruno Cadot; John Rendu; Soledad Monges; Valérie Biancalana; Susana Quijano-Roy; Mai Thao Bui; Anaïs Chanut; Angéline Madelaine; Emmanuelle Lacène; Maud Beuvin; Helge Amthor; Laurent Servais; Yvan de Feraudy; Marcela Erro; Maria Saccoliti; Osorio Abath Neto; Julien Fauré; Béatrice Lannes; Vincent Laugel; Sandra Coppens; Fabiana Lubieniecki; Ana Buj Bello; Nigel Laing; Teresinha Evangelista; Jocelyn Laporte; Johann Böhm; Norma B Romero
Journal:  Acta Neuropathol Commun       Date:  2022-07-09       Impact factor: 7.578

Review 2.  Recent advances in understanding congenital myopathies.

Authors:  Gianina Ravenscroft; Robert J Bryson-Richardson; Kristen J Nowak; Nigel G Laing
Journal:  F1000Res       Date:  2018-12-11

Review 3.  Nemaline myopathies: a current view.

Authors:  Caroline A Sewry; Jenni M Laitila; Carina Wallgren-Pettersson
Journal:  J Muscle Res Cell Motil       Date:  2019-06-21       Impact factor: 2.698

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.